Dr. Peter S. Staats Net Worth

The estimated Net Worth of Peter S. Staats is at least $928 mil dollars as of 13 December 2018. Dr Staats owns over 10,000 units of ElectroCore Inc stock worth over $927,816 and over the last 6 years he sold ECOR stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Dr Staats ECOR stock SEC Form 4 insiders trading

Dr has made over 1 trades of the ElectroCore Inc stock since 2018, according to the Form 4 filled with the SEC. Most recently he bought 10,000 units of ECOR stock worth $48,300 on 13 December 2018.

The largest trade he's ever made was buying 10,000 units of ElectroCore Inc stock on 13 December 2018 worth over $48,300. On average, Dr trades about 5,000 units every 0 days since 2018. As of 13 December 2018 he still owns at least 154,636 units of ElectroCore Inc stock.

You can see the complete history of Dr Staats stock trades at the bottom of the page.

Dr. Peter S. Staats biography

Dr. Peter S. Staats is the Chief Medical Officer at ElectroCore Inc.

How old is Dr Staats?

Dr Staats is 56, he's been the Chief Medical Officer of ElectroCore Inc since . There are 12 older and 4 younger executives at ElectroCore Inc. The oldest executive at ElectroCore Inc is Peter Cuneo, 76, who is the Independent Director.

What's Dr Staats's mailing address?

Peter's mailing address filed with the SEC is 150 ALLEN ROAD, SUITE 201, , BASKING RIDGE, NJ, 07920.

Insiders trading at ElectroCore Inc

Over the last 6 years, insiders at ElectroCore Inc have traded over $541,551 worth of ElectroCore Inc stock and bought 3,996,513 units worth $5,852,816 . The most active insiders traders include James L L Tullis, Joseph P Errico, eThomas J. Errico. On average, ElectroCore Inc executives and independent directors trade stock every 38 days with the average trade being worth of $422,718. The most recent stock trade was executed by Thomas J. Errico on 15 August 2024, trading 5,000 units of ECOR stock currently worth $30,600.

What does ElectroCore Inc do?

electrocore is, a us based electroceutical healthcare company, which is developing a range of non-invasive vagus nerve stimulation (nvns) patient administered therapies for the treatment of multiple conditions in neurology, psychiatry, gastroenterology and other fields. initial focus is on primary headache (migraine and cluster headache), with trials continuing in epilepsy, gastric motility disorders, depression and anxiety. electrocore, which was founded in 2005, has more than 30 employees and full time consultants with offices in the us (head office), germany (german and european head office), uk, italy, australia, and canada.

Complete history of Dr Staats stock trades at ElectroCore Inc

ElectroCore Inc executives and stock owners

ElectroCore Inc executives and other stock owners filed with the SEC include:

• Daniel Goldberger,
  Chief Executive Officer, Director
• Joseph Errico,
  Director
• Brian Posner,
  Chief Financial Officer
• Daniel S. Goldberger,
  CEO & Director
• Brian M. Posner,
  CFO & Corp. Sec.
• Joseph P. Errico,
  Co-Founder, Principal Investor & Director
• Hans Vitzthum,
  Investor Relations
• Thomas Patton,
  Independent Director
• Stephen Ondra,
  Independent Director
• Trevor Moody,
  Independent Director
• John Gandolfo,
  Independent Director
• Thomas Errico,
  Independent Director
• Peter Cuneo,
  Independent Director
• Sylvester Steele,
  Vice President, General Manager of the Government Channels Business Unit
• Eric Liebler,
  Senior Vice President - Neurology
• Mike Romaniw,
  Executive Vice President - Systems & Operations
• Michael Atieh,
  Independent Chairman of the Board
• Dr. Peter S. Staats M.B.A., M.D.,
  Chief Medical Officer
• Eric J. Liebler,
  Sr. VP of Neurology
• Dr. Peter S. Staats,
  Chief Medical Officer
• Carrie Kochek,
  Sr. Director of HR
• Iain Strickland Ph.D.,
  VP of Global Sales & Strategy
• Jackie Dorsky,
  VP of Marketing
• Michael Romaniw,
  Exec. VP of Systems & Operations
• Julie Ann Goldstein,
  Director
• James L L Tullis,
  Director
• Nicholas Colucci,
  Director
• Global Health Innovation Fu...,
  10% owner
• Carrie Smith Cox,
  Director
• Ventures Ii, Llc Core,
  10% owner
• Francis R. Amato,
  Chief Executive Officer
• Peter S. Staats,
  Chief Medical Officer
• Glenn S. Vraniak,
  Chief Financial Officer
• Charles Steve Theofilos,
  
• Patricia Wilber,
  Director